• Amplifon completed the sale of its India business to Hearzap (Hearing Solutions Private Limited) following a strategic review under its Fit4Growth program.
• The divested unit included about 115 clinics, 460 employees, and generated roughly EUR 12 million of revenue in 2025.
• The India operations had diluted group EBITDA; the disposal is expected to lift the adjusted EBITDA margin.
• No material non-recurring charges are expected from the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amplifon S.p.A. published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.